Related Experiment Video
Updated: Sep 21, 2025

07:14
A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
14.5K
p53-Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
Xiaonan Chen1, Hao Lin1, Weiyao Xiong2
1Department of Cardiology Ninth People's HospitalShanghai Jiao Tong University School of Medicine Shanghai China.
Journal of the American Heart Association
|June 3, 2022
Summary
Aging accelerates heart failure with preserved ejection fraction (HFpEF) by activating p53. This study reveals p53
Area of Science:
- Cardiology
- Aging Research
- Molecular Biology
Background:
- Heart failure with preserved ejection fraction (HFpEF) affects 50% of heart failure patients, with age and gender biases.
- While HFpEF is common in the elderly, young patients are increasingly observed, necessitating research into underlying mechanisms.
- The role of aging in HFpEF pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the role of aging and p53 activation in the development of HFpEF.
- To determine how telomere shortening and mitochondrial function are affected in an aging HFpEF model.
Main Methods:
- Induction of HFpEF in wild-type and telomerase RNA component knockout mice using a high-fat diet and Nω-Nitro-L-arginine methyl ester hydrochloride.
- Assessment of cardiac function, histological changes, and mitochondrial respiration.
- Utilized myocardial-specific p53 knockout mice to evaluate p53's role.
Main Results:
- HFpEF developed equally in male and female mice, with cardiac wall thickening preceding diastolic dysfunction.
- Accelerated HFpEF onset occurred in telomerase RNA component knockout mice compared to wild-type.
- Mitochondrial respiration shifted from compensatory to dysfunctional states in a p53-dependent manner; loss of p53 delayed HFpEF onset.
Conclusions:
- p53 activation is a key factor in HFpEF pathogenesis.
- Short telomere mice exhibit basal p53 activation and mitochondrial upregulation of mtDNA-encoded genes.
- Inhibition of myocardial p53 activation delays HFpEF development in a murine model.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology
62
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
62
Cardiomyopathy II: Dilated Cardiomyopathy
34
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
34
Cardiomyopathy V: Interprofessional Care
42
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
Imbalances in Cardiac Output
1.6K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
69
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
69

